Skip to content
About
About us
Our Capabilities
Our Facility
Our Team
Work at IDT
Advanced Therapies
Aseptic Fill & Finish
mRNA – ADCs
Specialty Orals
Psychedelics/Medicinal Cannabis
Oral Finished Dose
API & Intermediates
Active Pharmaceutical Ingredients
Investors
ASX Announcements
Share Price
Corporate Governance
Investor Presentations
Annual Reports
News
Contact
News
Home
»
News
»
Taylor Collison Analyst Report 21 April – IDT sterile license update
Taylor Collison Analyst Report 21 April – IDT sterile license update
April 21, 2023
|
News
The announcement can be viewed
here
Posts navigation
← Business Update – COVID-19 Stage 4
Herald Sun 6 May 2024 – Cancer Therapy Lab Plan →
